CD4-PP induces wound
closure and clears in vitro infection. (A) Uninfected
keratinocytes stimulated with CD4-PP showed
a decrease in Ki-67 on the mRNA level. (B) Representative confocal
imaging of Ki-67 protein expression shows a decrease in nuclear Ki-67
in CD4-PP-treated keratinocytes, depicting Ki-67 (green) and nucleus
(blue). (C) Densitometric analysis of nuclear Ki-67 staining in keratinocytes
with or without CD4-PP treatment. (D) Representative confocal images
of keratinocytes fixed immediately postscarring. (E,F) Representative
confocal images of MRSA-infected keratinocytes with or without CD4-PP
treatment 48 h after scarring, depicting actin (green) and nucleus
(blue). (G) Wound area size of MRSA-infected keratinocytes with or
without CD4-PP treatment 48 h postscarring, showing significantly
decreased wound area. (H) Representative confocal images of keratinocytes
infected with MRSA CCUG 31966 with or without CD4-PP treatment, depicting
nucleus (blue), LC3B (red), and p62 (green). (I) Densitometric analysis
of LC3B in MRSA-infected keratinocytes with or without CD4-PP treatment.
All microscopy imaging and densitometry analysis were performed in
three independent experiments, with each experiment consisting of
4–5 random view fields. The average integrated density of each
cell per set was used for statistical analyses (**p < 0.01, ***p < 0.001, unpaired t test).